SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-24-000142
Filing Date
2024-05-07
Accepted
2024-05-07 15:55:10
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 3-31-2024 form10q.htm   iXBRL 10-Q 1542655
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 50583
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 12907
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 12804
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 7025
11 image01.jpg GRAPHIC 10917
  Complete submission text file 0000874015-24-000142.txt   7296378

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ions-20240331.xsd EX-101.SCH 50155
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20240331_cal.xml EX-101.CAL 85433
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20240331_def.xml EX-101.DEF 263801
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240331_lab.xml EX-101.LAB 713120
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240331_pre.xml EX-101.PRE 382677
70 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1163590
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 24921599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)